Revvity | PKI - 負債





負債 変化する 日付
Agilent USD 3.36B 1000K 2026-03
Align Technology USD 116.04M 1.6M 2026-03
Bio Techne USD 200M 0 2026-06
Bio-Rad Laboratories USD 1.37B 7.8M 2026-06
Bruker USD 1.82B 153.5M 2026-06
Celltrion KRW 160.58B 733.3M 2026-03
Charles River Laboratories USD 3.06B 485.84M 2026-03
Cspc Pharmaceutical CNY 641.11M 146.11M 2025-12
Danaher USD 26.56B 8.07B 2026-06
Dentsply International USD 2.33B 137M 2026-03
Deva Holding AS TRY 5.3B 871.93M 2023-09
Dianthus Therapeutics USD 1.36M 79K 2026-03
Divis Laboratories Ltd INR 70M 30M 2026-03
Edwards Lifesciences USD 600M 105.4M 2026-03
Illumina USD 2.54B 9M 2026-03
Intuitive Surgical USD 0 0 2025-03
IQVIA Holdings USD 16.24B 408M 2026-06
Kangmei Pharma CNY 173.71M 42.08M 2026-03
Knight Therapeutics CAD 77.91M 28.33M 2025-12
Laboratorios Farma EUR 129.3M 14.89M 2025-06
Laboratory Of America USD 7.24B 714.6M 2026-03
Malin Corporation EUR 100K 0 2023-12
Medical Developments International AUD 1.99M 152K 2025-06
Mesa Laboratories USD 204.98M 7.27M 2024-09
Mettler Toledo International USD 2.23B 76.47M 2026-03
Myriad Genetics USD 59.3M 19.7M 2025-03
Neuren Pharmaceuticals AUD 0 0 2024-12
OraSure Technologies USD 782K 465K 2024-06
Organigram Holdings CAD 8.2M 554K 2026-03
Ovoca Bio EUR 0 0 2021-06
Pacific Biosciences Of California USD 892.24M 653K 2023-12
Pharma Mar EUR 45.84M 1.7M 2026-06
Qiagen NV USD 1.65B 165.82M 2026-03
Quest Diagnostics USD 6.41B 179M 2026-03
Quidel USD 2.87B 40.8M 2026-03
Repligen USD 690.94M 144.36M 2026-06
Revvity USD 3.35B 48.03M 2026-03
Sartorius EUR 4.05B 248.8M 2026-06
Sino Biopharmaceutical CNY 9.71B 33.98M 2024-12
Thermo Fisher Scientific USD 43.16B 3.78B 2026-03
Tilray USD 640.95M 35.17M 2022-06
Waters USD 5.57B 4.08B 2026-03
Zealand Pharma A/S 414M 8.23M 2026-03
Zz Pientze Pharmaceu CNY 1.07B 2.82M 2026-03